MONTREAL, May 9, 2017 /PRNewswire/ - Oligo Medic announced that Jerett A. Creed has joined the company in the position of Chief Executive Officer.
Mr. Creed has more than 20 years of medtech experience spanning multiple disease sectors and leadership roles with a strong focus on international commercialization, capital markets and business development. Mr. Creed has participated in a leadership role on transactions exceeding $650 million in M&A activity including 2 public offerings. Most recently Mr. Creed was in charge of launching Oligo Medic's JointRep™ product throughout Latin America. Prior to that, Mr. Creed was founder and CEO of Cardigant Medical, a formerly public company focused on the development and commercialization of novel peptide mimetics for treating vascular disease. Before that Mr. Creed was interim Chief Financial Officer for a publicly traded oil and gas company providing leadership through multiple acquisitions and one divestiture. Mr. Creed began his career with Johnson and Johnson initially focused on manufacturing and product development of early angioplasty balloons and bare metal stents ultimately spending more than a decade with the company finishing his tenure as Director of Business Development for an internally funded stem cell based incubator. Mr. Creed holds a Master of Science degree in Accounting and a Bachelor of Science degree in Engineering both from the University of Miami.
About Oligo Medic
Oligo Medic is a medical device company specialized in biomaterials for regenerative medicine. The company's leading product JointRep™ is a paradigm-shifting solution indicated for the treatment of articular cartilage in all body joints. For more information, you can visit www.oligomedic.com.
SOURCE Oligo Medic inc.